Recruiting NCT06544876

NCT06544876 Balance Control and Recovery in Diabetes Peripheral Neuropathy

◆ AI Clinical Summary

Plain-language summary for patients

Clinical Trial Summary
NCT ID	NCT06544876
Status	Recruiting
Phase	—
Sponsor	Lisa Griffin
Condition	Diabetic Peripheral Neuropathy
Study Type	INTERVENTIONAL
Enrollment	60 participants
Start Date	2023-09-12
Primary Completion	2026-08-31

Trial Parameters

Condition Diabetic Peripheral Neuropathy

Sponsor Lisa Griffin

Study Type INTERVENTIONAL

Phase N/A

Enrollment 60

Sex ALL

Min Age 50 Years

Max Age 99 Years

Start Date 2023-09-12

Completion 2026-08-31

All Conditions

Diabetic Peripheral Neuropathy Diabetic Peripheral Neuropathy Type 2 Diabetic Peripheral Neuropathy Type 2 - Uncontrolled Healthy Aging

Interventions

sit-to-standstand to sitstanding perturbation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Your Age

Your Sex

Brief Summary

In this study the effects of diabetic peripheral neuropathy will be assessed on balance control, balance recovery, and muscle electrical activity in adults over 50 years. Aim 1: Determine muscle activity and balance control during a sit-to-stand in adults age above 50 with and without diabetic peripheral neuropathy. Aim 2: Assess local balance recovery and latency responses to lateral surface perturbation during quiet standing.

Eligibility Criteria

Inclusion Criteria: * Type II diabetes with peripheral neuropathy Exclusion Criteria: * Foot ulcer * Partial amputation * Have experience of Stroke * Painful neuropathy * Inability to stand or walk independently

Related Trials

NCT06287736

Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy

View Trial →

NCT07391995

New Diagnostic Tool (MinION) for Identifying Microorganisms in Foot Wounds of Patients Living With D

View Trial →

NCT06544876

Balance Control and Recovery in Diabetes Peripheral Neuropathy

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE DIABETIC PERIPHERAL NEUROPATHY TRIALS

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology